1- Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran , abdorrezamoghadasi@gmail.com
2- Department of Neurology, Poursina Hospital, Guilan University of Medical Sciences, Rasht, Iran
Abstract: (2182 Views)
This article has no abstract.
Full-Text [PDF 597 kb]
(852 Downloads)
| |
Full-Text (HTML) (954 Views)
Highlights
● In recent years, there have been reports of hemorrhage in other demyelinating diseases of the CNS. A look at these cases can help us understand the less known symptoms of the demyelinating diseases of the CNS.
● HDLC can be defined as hemorrhagic lesions that have a hemorrhagic mechanism due to CNS tissue demyelination.
● Recognition of HDLC as a separate spectrum disorder makes it necessary to investigate the immunological basis of this new entity.
Type of Study:
Letter to Editor |
Subject:
General Received: 2019/05/3 | Accepted: 2019/08/14 | Published: 2019/07/1